Inventor · disambiguated record
Daniel Plaksin
Also filed as: PLAKSIN DANIEL
16 granted patents·11 pending applications·67 citations·filing 2001–2022
93Inventor score
Files withFERRING BV9FERRING INT CENTER SA4COTTINGHAM IAN3BIO TECHNOLOGY GENERAL ISRAEL1HAGAY YOCHEVED1
Top patents by PatentIndex Score
27 records- 0193US11952407B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2021·Granted Apr 9, 2024·2 cites·5 claims
- 0293US10995128B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2017·Granted May 4, 2021·7 cites·8 claims
- 0391US11292824B2Pharmaceutical preparation comprising recombinant hCGFERRING BV·Filed 2019·Granted Apr 5, 2022·3 cites·6 claims
- 0490US9771407B2Pharmaceutical preparationFERRING INT CENTER SA·Filed 2016·Granted Sep 26, 2017·8 cites·15 claims
- 0589US10526390B2Pharmaceutical preparation comprising recombinant HcGFERRING BV·Filed 2017·Granted Jan 7, 2020·6 cites·12 claims
- 0688US9546204B2Recombinant FSH including alpha 2,3- and alpha 2,6-sialylationFERRING INT CENTER SA·Filed 2014·Granted Jan 17, 2017·8 cites·17 claims
- 0788US8951967B2Recombinant FSH including alpha 2,3- and alpha 2,6-sailylationCOTTINGHAM IAN·Filed 2009·Granted Feb 10, 2015·11 cites·40 claims
- 0885US9676835B2Pharmaceutical preparation comprising recombinant HcGFERRING BV·Filed 2014·Granted Jun 13, 2017·6 cites·20 claims
- 0984US8975226B2Pharmaceutical preparation comprising recombinant hCGCOTTINGHAM IAN·Filed 2010·Granted Mar 10, 2015·6 cites·25 claims
- 1083US12234272B2Pharmaceutical preparation comprising recombinant HCGFERRING BV·Filed 2022·Granted Feb 25, 2025·0 cites·5 claims
- 1176US9757469B2Pharmaceutical preparationCOTTINGHAM IAN·Filed 2012·Granted Sep 12, 2017·6 cites·27 claims
- 1272US11306136B2Selective IL-6-trans-signalling inhibitor compositionsFERRING BV·Filed 2019·Granted Apr 19, 2022·0 cites·13 claims
- 1369US10519218B2Selective IL-6-trans-signalling inhibitor compositionsFERRING BV·Filed 2015·Granted Dec 31, 2019·1 cites·8 claims
- 1469US2022275056A1Selective il-6-trans-signalling inhibitor compositionsFERRING BV·Filed 2022·Application pending·0 cites
- 1566US10464984B2Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropinFERRING BV·Filed 2016·Granted Nov 5, 2019·1 cites·17 claims
- 1659US7132510B2Specific human antibodies for selective cancer therapyBIO TECHNOLOGY GENERAL ISRAEL·Filed 2001·Granted Nov 7, 2006·2 cites·12 claims
- 1747US2005069955A1Antibodies and uses thereofFiled 2004·Application pending·0 cites
- 1846US10952959B2Fast disintegrating pharmaceutical compositionFERRING BV·Filed 2018·Granted Mar 23, 2021·0 cites·11 claims
- 1945US2002012909A1Small functional units of antibody heavy chain variable regionsFiled 2001·Application pending·0 cites
- 2045US2009220486A1Antibodies and uses thereofPLAKSIN DANIEL·Filed 2008·Application pending·0 cites
- 2145US2005152906A1Specific human antibodiesFiled 2004·Application pending·0 cites
- 2244US2004208877A1Antibodies and uses thereofFiled 2003·Application pending·0 cites
- 2341US2005266009A1Antibodies and uses thereofSAVIENT PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2440US2004001839A1Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereofFiled 2001·Application pending·0 cites
- 2540US2007149768A1Specific human antibodies for selective cancer therapyHAGAY YOCHEVED·Filed 2006·Application pending·0 cites
- 2639US2004002450A1Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereofFiled 2001·Application pending·0 cites
- 2739US2004001822A1Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Plaksin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →